1. bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital2. Once valued at $10B, bluebird bio sold to private equity firms for $29M3. 药时代文章、短视频4. 其它公开资料药渡媒体商务合作媒体公关 | 新闻会议发稿张经理:18600036371(微信同号)
1. bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital2. Once valued at $10B, bluebird bio sold to private equity firms for $29M3. 药时代文章、短视频4. 其它公开资料药渡媒体商务合作媒体公关 | 新闻会议发稿张经理:18600036371(微信同号)